These outcomes, together with a preceding report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 assistance the thought of targeting ACKR3 as a singular method to modulate the opioid technique, which could open new therapeutic avenues for opioid-related Problems.At that point, Microsoft Advertising and